Publication | Open Access

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Hematological MalignancyTransplantationMarrow TransplantationMedicineStem Cell TransplantationHematologyHigh-dose ChemotherapyRadiation OncologyOncologyCell TransplantationHealth Sciences